← Open Payments lookup

GENNIE MULLEN: Open Payments

NPI 1447802137 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$203 in 12 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $330 · 2025 $203

Food & beverage: $203
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Eisai Inc.2$33
Otsuka America Pharmaceutical, Inc.2$32
PFIZER INC.1$24
Novartis Pharmaceuticals Corporation1$15
GlaxoSmithKline, LLC.1$14
Novo Nordisk Inc1$14

Products named: FARXIGA, CAPLYTA, Leqembi, REXULTI, PREVNAR 20, LEQVIO, TRELEGY ELLIPTA, Ozempic.

Industry payments across KS — which companies pay providers there.